[e-drug] Import tariffs on medicines

E-DRUG: Import tariffs on medicines
---------------------------------

New analysis reveals Iran, Nigeria, Nepal among the highest; countries should
strive to abolish medicine tariffs
http://www.policynetwork.net/health/publication/death-and-taxes-2010

LONDON, 25 JANUARY -- New analysis released today by think tank
International Policy Network shows that import tariffs on medicines are
gradually falling throughout the world, but remain stubbornly high in some
countries - acting as a tax on the sick. The global average is now 3.5%,
down from 5% in 2005. However, this masks exceptionally high tariff rates
in countries such as Iran (30%), Burundi (15%), Nigeria (14.8%) and Tunisia
(13%), the study shows.

Other low-income countries such as Ghana and Bangladesh increase the cost of
medicines with import duties of between 6% and 8% - self-defeating in
countries with such high disease burdens.

Some countries levy especially punitive tariffs on antibiotics, hampering
the fight against infectious disease. The worst offenders are Nigeria
(20%), Burundi (15%), Nepal (15%) and Congo (15%).

In contrast, countries like Rwanda, Kenya, Gabon and Saudi Arabia have
recently abolished import duties on medicines, joining the likes of wealthy
European Union countries, Canada and the USA, as well as poorer countries
like Benin, Malawi, and South Africa. Indian tariffs have fallen from 35%
to 10% since 2001.

Study author Philip Stevens said: "Many lower income countries suffer high
rates of diseases that are easy to treat or prevent with appropriate
medicines. Lack of proper health systems means that many people have to pay
for medicines out of their own pockets. It is therefore unconscionable that
governments still tax sick people".

"All countries should strive to abolish medicine tariffs, and join the
increasing number of countries that do not impose these unfair taxes on the
sick," Stevens said.

The report is available here:
http://www.policynetwork.net/health/publication/death-and-taxes-2010

IPN has also launched a new interactive global map of medicine tariffs:
http://www.policynetwork.net/health/map
IPN (www.policynetwork.net) is a global think-tank based in London, and is a
non-profit, non-partisan organisation. IPN runs campaigns seeking to educate
the public about the importance of markets and market institutions in the
context of global policies relating to development, trade, health,
accountability and the environment.

E-DRUG: Import tariffs on medicines (2)
--------------------------------

"Research" from IPN needs to be taken with a pinch of salt for very
substantive reasons. They support free trade, but also advocate "free
choice" on intellectual property rights. The reasons for the
equivocation on IPRs may well give grounds for justification on tariffs,
particularly if infant industries are to be developed to reduce
dependence on imports especially for generics. But getting this from IPN
is difficult. Good luck.

Riaz K Tayob
South Africa
Riaz K Tayob <riaz.tayob@gmail.com>